MEDICINAL COMPOSITION CONTAINING MELTRIN ANTAGONIST

摘要

Mainly concerning the pharmaceutical field, it is intended to exert an inhibitory effect on the function of meltrin a of promoting the differentiation of adipocytes by preparing a compound serving as an antagonist to meltrin a (for example, an antisense inhibiting the expression of a meltrin a gene or an anti-meltrin a antibody capable of inhibiting the physiological activity of meltrin a) and administering the same. By employing such a meltrin a antagonist as described above as the active ingredient, it becomes possible to provide a preventive/remedy which is efficacious against fatness, obesity or various diseases caused by obesity or relating thereto such as diabetes.